论文部分内容阅读
美国关于 LDL-C 水平的建议使得多数西方国家的成年人处于他汀的治疗范围内他汀的剂量有可能超过现在使用剂量8倍以上阿托伐他汀剂量增加8倍并未降低死亡率临床试验中的副作用未被充分报告任何非致死性事件的下降都可以被更多、更严重的副作用所抵消
US recommendations for LDL-C levels that most adults in Western countries are on statin treatment statins may exceed statin doses by more than 8 times the current dose and at least 8 times atorvastatin dose does not reduce mortality In clinical trials Side effects not fully reported Any decline in non-fatal events can be offset by more and more serious side effects